Emcure Pharmaceuticals Ltd. NSE: EMCURE | BSE: 544210

Emcure Pharma Live Share Price Today, Share Analysis and Chart

Name: Emcure Pharmaceuticals Ltd.: Is Infosys Ltd. worth buying?
Item: Emcure Pharmaceuticals Ltd.
Rating: 3.064666625
Author: Trendlyne DVM scores

Strong Performer, Getting Expensive

about

Incorporated in 1981, Emcure Pharmaceuticals is engaged in developing, manufacturing and globally marketing a broad range of pharmaceutical products across several major therapeutic areas. The company's product portfolio includes orals, injectables a...

1404.00 -24.00 (-1.68%)

57.93% Gain from 52W Low

174.8K

NSE+BSE Volume

NSE 29 Dec, 2025 3:31 PM (IST)

Loading... You have run out of DVM views!

Subscribe now to see details

High Financial Strength

- / 100

Mid Valuation

- / 100

Technically Moderately Bullish

64.8 / 100

Strong Performer, Getting Expensive These stocks are strong in quality and technicals but have medium valuation. At somewhat expensive valuations, investors should be cautious before buying View Similar Embed DVM

1,664

1Yr Price target upside is 18%

6 analysts

Emcure Pharma Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Emcure Pharma Live Share Price Today, Share Analysis and Chart

Incorporated in 1981, Emcure Pharmaceuticals is engaged in developing, manufacturing and globally marketing a broad range of pharmaceutical products across several major therapeutic areas. The company's product portfolio includes orals, injectables a...

57.93% Gain from 52W Low

SWOT Analysis

Emcure Pharma Live Price Chart